AVBP
ArriVent BioPharma, Inc.
29.70$
+2.9%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| – | – | – | – | – | |
| – | +373.0% | +113.2% | +21.8% | +94.1% | |
| – | +114.6% | +49.9% | +57.7% | +58.0% | |
| – | +324.4% | +102.1% | +26.4% | +88.2% | |
| – | – | – | – | – | |
| – | – | – | – | – | |
| – | – | – | – | – | |
| – | – | – | – | – | |
| – | – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.